Cargando…
Ventricular tachycardia associated with lacosamide co-medication in drug-resistant epilepsy()
We report a case of sustained ventricular tachycardia following the initiation of lacosamide as adjunctive epilepsy treatment. A 49-year-old male with intractable frontal lobe seizures experienced severe ventricular tachycardia following the addition of 400 mg lacosamide to his existing regimen of c...
Autores principales: | DeGiorgio, Andrew C., Desso, Tamara E., Lee, Lance, DeGiorgio, Christopher M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150657/ https://www.ncbi.nlm.nih.gov/pubmed/25688050 http://dx.doi.org/10.1016/j.ebcr.2012.10.001 |
Ejemplares similares
-
Editorial: Sudden Death in Epilepsy: Basic and Translational Research
por: DeGiorgio, Christopher M.
Publicado: (2018) -
Vitamin D3 for the Treatment of Epilepsy: Basic Mechanisms, Animal Models, and Clinical Trials
por: Pendo, Kevin, et al.
Publicado: (2016) -
Refractory Ventricular Tachycardia and Seizures With Lacosamide Overdose
por: Marcellino, Chris, et al.
Publicado: (2022) -
Editorial: Sudden Unexpected Death in Epilepsy: Bio-markers, Mechanisms, Risk Identification and Prevention
por: Surges, Rainer, et al.
Publicado: (2019) -
Ranking the Leading Risk Factors for Sudden Unexpected Death in Epilepsy
por: DeGiorgio, Christopher M., et al.
Publicado: (2017)